Clinical Trial: A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers

Share this article:
Clinical Trial: A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers

Sponsor and Collaborators

University of Alabama at Birmingham
National Cancer Institute (NCI)

Contact
Contact: Patty Bunch, BSN
205-930-8648
pbunch@uabmc.edu

Principal Investigator
Ronald D Alvarez, MD University of Alabama at Birmingham

ClinicalTrials.gov Identifier
NCT00964756
Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Gynecologic Cancer Clinical Trials

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs